BMC Psychiatry · 2015 · 26 citations · 31 references
MedicinePharmacotherapyPsychiatryClinical NeuroscienceNeural EngineeringPsychopharmacologyAntidepressant TherapyDepressionDepression ManagementNeurostimulationTreatment-resistant Psychiatric DisordersVagus Nerve StimulationAdjunctive Antidepressant TherapyImplantable Vagus Nerve StimulationMajor DepressionMood Disorder NeuromodulationRemission In DepressionRemission MeasurementTherapeutic NeuromodulationVagus Nerve Stimulators
BACKGROUND: Limited therapeutic options are available for patients with treatment-refractory major depression who do not respond to routinely available therapies. Vagus nerve stimulation showed adjunctive antidepressant effect in chronic treatment resistant depression, even though available studies rarely exceed 2-year follow up. We report a naturalistic 5-year follow up of five patients who received VNS implant for resistant depression (3 patients with major depressive disorder and 2 with bipolar disorder). METHODS: Response was defined as a reduction of the 17-item HDRS total score ≥50% with respect to baseline, remission as a score ≤7. RESULTS: Response and remission rates were both 40% (2/5) after 1 year, and 60% (3/5) at 5 years. Two patients withdrew from the study because of side effects or inefficacy of stimulation. CONCLUSIONS: Our case series showed that long-term VNS may be effective in reducing severity of depression in a small but significant minority of patients, although two patients had stimulation terminated because of adverse effects and/or refusal to continue the study.
31
The definition and meaning of treatment-resistant depression.
Harold A. Sackeïm · PubMed · 2001 · 782 citations